(Post-pandemic Era)-Global Gene Therapy-based Drug Market Segment Research Report 2022
- Published Date: 2022-04-19
- Report ID: 127866
- Pages: 175
-
Format:
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. XYZResearchreleased the Global Gene Therapy-based Drug Market Segment Research Report 2022, which aims to sort out the development status and trends of the Gene Therapy-based Drug industry at home and abroad, estimate the overall market scale of the Gene Therapy-based Drug industry and the market share of major countries, analyze the development potential of each segment of the Gene Therapy-based Drug industry, and study and judge the downstream market demand of Gene Therapy-based Drug through systematic research, Analyze the competition pattern of Gene Therapy-based Drug, so as to help solve the pain points of various stakeholders in Gene Therapy-based Drug industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Gene Therapy-based Drug Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Gene Therapy-based Drug Market
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Major Type of Gene Therapy-based Drug Covered in XYZResearch report:
Viral Gene Delivery System
Non-viral Gene Delivery System
Application Segments Covered in XYZResearch Market
Neurological Diseases
Cancer
Other
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Gene Therapy-based Drug Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Gene Therapy-based Drug Market by Value
2.2.1 Global Gene Therapy-based Drug Revenue by Type
2.2.2 Global Gene Therapy-based Drug Market by Value (%)
2.3 Global Gene Therapy-based Drug Market by Production
2.3.1 Global Gene Therapy-based Drug Production by Type
2.3.2 Global Gene Therapy-based Drug Market by Production (%)
3. The Major Driver of Gene Therapy-based Drug Industry
3.1 Historical & Forecast Global Gene Therapy-based Drug Demand
3.2 Largest Application for Gene Therapy-based Drug (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Gene Therapy-based Drug Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of Gene Therapy-based Drug Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Gene Therapy-based Drug Production, Demand (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Gene Therapy-based Drug Production, Demand (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Gene Therapy-based Drug Production, Demand (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Gene Therapy-based Drug Production, Demand (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Gene Therapy-based Drug Production, Demand (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Gene Therapy-based Drug Production, Demand (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Gene Therapy-based Drug Production, Demand (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Gene Therapy-based Drug Average Price Trend
12.1 Market Price for Each Type of Gene Therapy-based Drug in US (2018-2022)
12.2 Market Price for Each Type of Gene Therapy-based Drug in Europe (2018-2022)
12.3 Market Price for Each Type of Gene Therapy-based Drug in China (2018-2022)
12.4 Market Price for Each Type of Gene Therapy-based Drug in Japan (2018-2022)
12.5 Market Price for Each Type of Gene Therapy-based Drug in India (2018-2022)
12.6 Market Price for Each Type of Gene Therapy-based Drug in Korea (2018-2022)
12.7 Market Price for Each Type of Gene Therapy-based Drug in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 Gene Therapy-based Drug Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of Gene Therapy-based Drug
14. Gene Therapy-based Drug Competitive Landscape
14.1 Biogen
14.1.1 Biogen Company Profiles
14.1.2 Biogen Product Introduction
14.1.3 Biogen Gene Therapy-based Drug Sales, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Novartis
14.2.1 Novartis Company Profiles
14.2.2 Novartis Product Introduction
14.2.3 Novartis Gene Therapy-based Drug Sales, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Gilead Sciences
14.3.1 Gilead Sciences Company Profiles
14.3.2 Gilead Sciences Product Introduction
14.3.3 Gilead Sciences Gene Therapy-based Drug Sales, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Sarepta Therapeutics
14.4.1 Sarepta Therapeutics Company Profiles
14.4.2 Sarepta Therapeutics Product Introduction
14.4.3 Sarepta Therapeutics Gene Therapy-based Drug Sales, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Alnylam Pharmaceuticals
14.5.1 Alnylam Pharmaceuticals Company Profiles
14.5.2 Alnylam Pharmaceuticals Product Introduction
14.5.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Sales, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Amgen
14.6.1 Amgen Company Profiles
14.6.2 Amgen Product Introduction
14.6.3 Amgen Gene Therapy-based Drug Sales, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Spark Therapeutics
14.7.1 Spark Therapeutics Company Profiles
14.7.2 Spark Therapeutics Product Introduction
14.7.3 Spark Therapeutics Gene Therapy-based Drug Sales, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Akcea Therapeutics
14.8.1 Akcea Therapeutics Company Profiles
14.8.2 Akcea Therapeutics Product Introduction
14.8.3 Akcea Therapeutics Gene Therapy-based Drug Sales, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 bluebird bio
14.9.1 bluebird bio Company Profiles
14.9.2 bluebird bio Product Introduction
14.9.3 bluebird bio Gene Therapy-based Drug Sales, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Sunway Biotech
14.10.1 Sunway Biotech Company Profiles
14.10.2 Sunway Biotech Product Introduction
14.10.3 Sunway Biotech Gene Therapy-based Drug Sales, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 SIBIONO
14.12 AnGes
14.13 Orchard Therapeutics
14.14 Human Stem Cells Institute
15. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
